Moslehi R, Devesa SS, Schairer C, Fraumeni JF. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst. 2006;98:936–9.

Article  PubMed  Google Scholar 

Wu Y, Liu X, Imber BS, Zhong QZ, Yang Y, Wu T, et al. Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: a SEER database analysis (2000-2015). Radiother Oncol. 2022;173:179–87.

Article  PubMed  Google Scholar 

Olszewski AJ, Desai A. Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys. 2014;88:642–9.

Article  PubMed  Google Scholar 

Holm F, Mikkelsen LH, Kamper P, Rasmussen PK, Larsen TS, Sjo LD, et al. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol. 2021;105:914–20.

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: B-cell lymphomas, Version 3, 2023. https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf.

Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:17–29.

Article  CAS  PubMed  Google Scholar 

Teckie S, Qi S, Chelius M, Lovie S, Hsu M, Noy A, et al. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma. Ann Oncol. 2017;28:1064–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2013;119:629–38.

Article  PubMed  Google Scholar 

Saul EE, Alderuccio JP, Reis IM, Zhao W, Iyer SG, Rodriguez G, et al. Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma. Am J Hematol. 2023;98:148–58.

Article  PubMed  Google Scholar 

Masuda Y, Takeuchi K, Kodama T, Fujisaki T, Imaizumi Y, Otsuka E, et al. Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis. Int J Clin Oncol. 2019;24:1620–8.

Article  PubMed  Google Scholar 

Desai A, Joag MG, Lekakis L, Chapman JR, Vega F, Tibshirani R, et al. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2017;129:324–32.

Article  CAS  PubMed  Google Scholar 

Hindso TG, Esmaeli B, Holm F, Mikkelsen LH, Rasmussen PK, Coupland SE, et al. International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma. Br J Ophthalmol. 2020;104:357–62.

Article  PubMed  Google Scholar 

Lee J, Yoon JS, Kim JS, Koom WS, Cho J, Suh CO. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization. Jpn J Clin Oncol. 2019;49:664–70.

Article  PubMed  Google Scholar 

Hoskin P, Popova B, Schofield O, Brammer C, Robinson M, Brunt AM, et al. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2021;22:332–40.

Article  PubMed  Google Scholar 

Yang X, Wang R, Yuan X, Yao S, Wang C, Cheng J. Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study. Radiat Oncol. 2022;17:208.

Article  CAS  PubMed  PubMed Central  Google Scholar